BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Stem Cells Market is expected to reach US$270.5 billion by 2025, TMR

  The global stem cells market is predicted to witness players seeking funds from international organizations for developing new therapies.

  February 24, 2020

   · 

  4 min read
• Biotech Bay

  Tinnitus Market Detailed Study Analysis with Forecast by 2025

  TMR Research estimates the future of the global tinnitus market with a thorough analysis of the forces governing the market.

  February 24, 2020

   · 

  3 min read
• 

  FDA

  Esperion Wins FDA Approval for its Oral, Cholesterol Lowering Medications

  The company is planning for its drug for cholesterol lowering medications to hit the streets by the end of March. It will provide a new option to all the patients.

  February 24, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  Report: Coronavirus Outbreak Could Cause Drug Shortages

  The U.S. Food and Drug Administration is compiling a list of drugs that are at risk of shortage if the outbreak in China continues to worsen.

  February 24, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Stada Buys 15 Over-the-Counter Products from GSK for $325 Million

  The brands Stada is picking up include venous treatment Venoruton, Coldrex for colds, Cetebe vitamin C supplements, Mebucaine for sore threats and Tavegyl for allergies, among others.

  February 24, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  Lundbeck’s Vyepti Wins Approval for Preventative Treatment of Migraines

  H. Lundbeck A/S is making a statement with its newly approved treatment for migraine, the first intravenous medication approved for the preventative treatment of migraine.

  February 24, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Harvard Researchers Partner with Chinese Scientists on Coronavirus Research

  Via a five-year collaborative research pact, Harvard and Guangzhou Institute will split $115 million in research funding provided by China Evergrande Group.

  February 24, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  BioCapital

  Team Dynamics: 15 Life Sciences Organizations Leading the Way

  The most recent BioSpace Ideal Employer Report revealed the impact of team dynamics on employees within life sciences organizations.

  February 24, 2020

   · 

  3 min read

   · 

  Porschia Parker
• 

  FDA

  Seqirus Wins Approval for Flu Vaccine for Adults 65 and Older

  Seqirus snagged approval for Fluad Quadrivalent, the first-and-only quadrivalent adjuvanted influenza vaccine developed to help protect adults 65 years and older against seasonal influenza.

  February 24, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Karius Raises $165 Million to Advance Infectious Disease Liquid Biopsy Tech

  “This transformative round will allow Karius to help more patients faster, fuel the next wave of clinical studies and accelerate technology innovation,” said Karius’ chief executive officer Mickey Kertesz.

  February 24, 2020

   · 

  2 min read

   · 

  Mark Terry